These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35571034)

  • 41. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
    Fang X; Liu X; Lu L; Liu G
    Front Oncol; 2021; 11():728181. PubMed ID: 34676164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [m
    Chen S; Dong R; Li Y; Wu H; Liu M
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):681-689. PubMed ID: 35673911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 44. Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights
    Dong X; Jin C; Chen D; Chen Y; Ye ZQ; Zhang X; Huang X; Zhang W; Gu DN
    Front Oncol; 2021; 11():737867. PubMed ID: 34604079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-Wide Identification and Analysis of the Methylation of lncRNAs and Prognostic Implications in the Glioma.
    He Y; Wang L; Tang J; Han Z
    Front Oncol; 2020; 10():607047. PubMed ID: 33489915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability.
    Yun D; Yang Z
    J Oncol; 2021; 2021():7408893. PubMed ID: 34594379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy.
    Wu X; Yang L; Wang J; Hao Y; Wang C; Lu Z
    Front Immunol; 2022; 13():897754. PubMed ID: 35619711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu S; Liu Z; Wu X; Luo H
    Front Oncol; 2022; 12():799475. PubMed ID: 35433487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
    Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration.
    Kang K; Xie F; Wu Y; Han C; Bai Y; Long J; Lian X; Zhang F
    Mol Ther Oncolytics; 2021 Sep; 22():431-443. PubMed ID: 34553030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer.
    He R; Man C; Huang J; He L; Wang X; Lang Y; Fan Y
    Front Genet; 2022; 13():870945. PubMed ID: 35464855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma.
    Chen Y; Guo Y; Li S; Xu J; Wang X; Ning W; Ma L; Qu Y; Zhang M; Zhang H
    Front Oncol; 2022; 12():789283. PubMed ID: 35311131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses.
    Yang Z; Gong W; Zhang T; Gao H
    Front Oncol; 2021; 11():729137. PubMed ID: 34660294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
    Gao X; Cai J
    Front Genet; 2022; 13():865204. PubMed ID: 35571063
    [No Abstract]   [Full Text] [Related]  

  • 59. Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma.
    Yan Y; Ren L; Liu Y; Liu L
    Front Genet; 2021; 12():763281. PubMed ID: 35154241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
    Zhang P; Liu G; Lu L
    Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.